Millie
your market intelligence analyst
Search Results
22 results
Your search is now limited to «Clinical Trials» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
GlobeNewswire 10/14/2019 08:30
Top-line data from Cohort 1 demonstrated clinically and statistically significant improvement in moderate to vigorous physical activity, as well as other physical activity parameters measured by continuous activity monitoring (actigraphy.
GlobeNewswire 09/11/2019 08:30
WESTMINSTER, Colo., Sept. 11, 2019 (GLOBE NEWSWIRE) -- (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that Gencaro atrial fibrillation clinical data from the GENETIC-AF Phase 2B trial have been selected for presentation at the Heart Failure Society of America (HFSA) being held September 13-16 in Philadelphia.
GlobeNewswire 08/29/2019 07:30
These results build upon the pivotal, Phase 3 bempedoic acid / ezetimibe combination tablet data announced last August, where the majority of patients were on background statin therapy,” said Tim M. Mayleben, president and chief executive officer of Esperion.
GlobeNewswire 08/27/2019 06:00
The Company has leveraged its proprietary technology platform to establish a broad portfolio of late-stage product candidates with three product candidates in Phase 3 trials – acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease.
GlobeNewswire 08/19/2019 07:30
HAMILTON, Bermuda, Aug. 19, 2019 (GLOBE NEWSWIRE) -- (Nasdaq: KNSA) ("Kiniksa"), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical need, today announced that it will present final data from an open-label, multicenter Phase 2 clinical trial of rilonacept in different pericarditis populations at the American Heart Association (AHA) Scientific Sessions 2019 at the Pennsylvania Convention Center in Philadelphia, PA.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications